The importance of alterations in innate lymphoid cell subsets in patients with non-small cell lung cancer and their role in tumorigenesis
Open Access
- 31 August 2023
- journal article
- research article
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 6 (2) , 251-257
Abstract
Objective. Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer-related morbidity and mortality. Diverse functions of innate lymphoid cells (ILCs) and NK cell subsets are investigated thoroughly in cancer immunotherapy. ILC and recently described NK cell subsets in NSCLC patients’ blood samples and tumor draining lymph nodes were investigated. Methods. The study included chemotherapy and/or radiotherapy-naive NSCLC patients with clinical stage T1-4N0-2M0 who underwent video-assisted mediastinal lymphadenectomy and 14 healthy controls. Mononuclear cells were isolated from peripheral blood of both groups and mediastinal lymph nodes of NSCLC patients. NK cells and ILC subsets were analyzed by flow cytometry. Results. Total NK cells are shown to be increased in peripheral blood of NSCLC patients compared to lymph nodes while the ratio of CD56dimCD16- exhausted NK cells is higher in lymph nodes than in blood samples of NSCLC patients. Compared to control group, peripheral blood ILC1 cells were lower in NSCLC patients, however ILC2 and ILC3 cells were significantly increased. However, mediastinal lymph nodes of NSCLC patients had decreased ratio of ILC2 and increased ratio of ILC3 cells than in peripheral blood of patients. NSCLC patients had significantly increased ratio of NKp44-ILC3 cells and decreased ratio of NKp44+ILC3 in lymph nodes. Conclusion. Decreased ratio of ILC1 cells is an important indicator of impaired anti-tumoral response. Increased in the ratio of NKp44-ILC3 cells in NSCLC patients may potentially contribute to tumor progression. These findings highlight the distinct roles of ILCs, which play a pivotal role in the pathogenesis of lung cancer.Keywords
Funding Information
- Research Fund of Istanbul University (Grant No: TOA-2017 20591)
This publication has 31 references indexed in Scilit:
- ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrenceJournal of Clinical Investigation, 2017
- Human CD56dimCD16dim Cells As an Individualized Natural Killer Cell SubsetFrontiers in Immunology, 2017
- Group 3 innate lymphoid cells regulate neutrophil migration and function in human deciduaMucosal Immunology, 2016
- Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organsScience, 2015
- NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structuresNature Communications, 2015
- Emerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue RepairImmunity, 2015
- Polarization of ILC2s in Peripheral Blood Might Contribute to Immunosuppressive Microenvironment in Patients with Gastric CancerJournal of Immunology Research, 2014
- Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trialThe Lancet, 2009
- Human NK cells: from HLA class I‐specific killer Ig‐like receptors to the therapy of acute leukemiasImmunological Reviews, 2008
- Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancerLung Cancer, 2002